47 results match your criteria: "Seibo International Catholic Hospital[Affiliation]"
Am J Clin Dermatol
November 2024
Division of Dermatological Science, Department of Dermatology, Nihon University School of Medicine, 30-1, Oyaguchikamicho, Itabashi-ku, Tokyo, 173-8610, Japan.
Am J Clin Dermatol
September 2024
Division of Dermatological Science, Department of Dermatology, Nihon University School of Medicine, 30-1, Oyaguchikamicho, Itabashi-ku, Tokyo, 173-8610, Japan.
Dermatol Ther (Heidelb)
July 2024
Atsuta Skin Clinic, Nagoya, Japan.
Introduction: Palmoplantar pustulosis (PPP) is a pruritic, painful, chronic dermatitis that greatly impacts functioning and quality of life and can be difficult to treat. Approved treatment options for PPP are limited, and many patients do not fully respond to current treatments.
Methods: This was a randomized, double-blind, placebo-controlled, phase 2 study in Japanese patients with moderate to severe PPP and inadequate response to topical treatment.
Mod Rheumatol
August 2024
Graduate School of Health Science, Morinomiya University of Medical Sciences, Osaka, Japan.
J Clin Epidemiol
October 2023
Department of Family Medicine, Seibo International Catholic Hospital, 2-5-1 Naka-Ochiai, Shinjyuku-ku, Tokyo, 161-8521, Japan.
Mod Rheumatol
March 2024
Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
J Gen Fam Med
May 2023
Japanese Association of Family Physicians Trainees, Japan Primary Care Association Tokyo Japan.
Background: Palmoplantar pustulosis (PPP) is a pruritic, painful, recurrent, and chronic dermatitis with limited therapeutic options.
Objective: To evaluate the efficacy and safety of apremilast for the treatment of Japanese patients with PPP and inadequate response to topical treatment.
Methods: This phase 2, randomized, double-blind, placebo-controlled study enrolled patients with Palmoplantar Pustulosis Area and Severity Index (PPPASI) total score ≥ 12 and moderate or severe pustules/vesicles on the palm or sole (PPPASI pustule/vesicle severity score ≥ 2) at screening and baseline with an inadequate response to topical treatment.
SSM Popul Health
June 2023
Advanced Preventive Medical Sciences, Chiba University Graduate School of Medical and Pharmaceutical Sciences, 1-33, Yayoicho, Inage-ku, Chiba-shi, Chiba, 263-8522, Japan.
BMJ Open
April 2023
Department of Dermatology, Radboud University, Nijmegen, The Netherlands.
Objectives: Evaluate the experiences and perceptions of patients participating in a simulated clinical trial and identify ways to enhance future patient-centric trial designs.
Design: International, multicentre, non-interventional, virtual clinical trial visits with patient debriefs and advisory boards.
Setting: Virtual clinic visits and accompanying advisory boards.
Arch Gerontol Geriatr
September 2023
Center for Preventive Medical Sciences, Chiba University, Inage-ku, Chiba, Japan; Center for Gerontology and Social Science, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
J Am Geriatr Soc
June 2023
Department of Social Preventive Medical Sciences, Center for Preventive Medical Sciences, Chiba University, Chiba, Japan.
Background: Frailty is the highest risk factor for incident disability and mortality. Social participation is a modifiable factor for reducing adverse outcomes among independent older adults. However, the association between social participation and incident disability and mortality among frail older adults remains unclear.
View Article and Find Full Text PDFJ Dermatol
March 2023
Department of Dermatology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
JAAD Int
September 2022
Department of Dermatology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
J Intensive Care
July 2022
Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Respir Investig
July 2022
Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
J Med Virol
July 2022
Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Mod Rheumatol
July 2022
Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan.
Synovitis-Acne-Pustulosis-Hyperostosis-Osteitis (SAPHO) syndrome is a rare inflammatory osteoarticular disorder, which encompassed many diseases, including pustulotic arthro-osteitis (PAO). Musculoskeletal manifestations, including osteitis, synovitis, and hyperostosis, are the hallmarks of the SAPHO syndrome and affect a variety of regions of the body. Recent survey indicated that more than 80% of cases of SAPHO syndrome in Japan were PAO, originally proposed by Sonozaki et al.
View Article and Find Full Text PDFClin Otolaryngol
March 2022
Department of Public Health, School of Medicine, International University of Health and Welfare, Narita, Chiba, Japan.
Clin Exp Nephrol
December 2021
Division of Clinical Nephrology and Rheumatology, Niigata University, Niigata, Japan.
J Clin Epidemiol
October 2021
Department of Family Medicine, Seibo International Catholic Hospital, 2-5-1 Naka-Ochiai, Shinjyuku-ku, Tokyo, 161-8521, Japan.
Objectives: We aimed to evaluate the characteristics, quality, and related factors of the Japanese Clinical Practice Guidelines (CPGs) published in recent years.
Study Design And Setting: In this cross-sectional, meta-epidemiological study, we conducted a Google search for CPGs published by 30 Japanese medical societies that are the basis for training specialties between 2018 and 2019. We used the Appraisal of Guidelines for Research & Evaluation II (AGREE II) tool and the Reporting Items for practice Guidelines in HealThcare (RIGHT) statement to evaluate the quality.
J Dermatol Sci
March 2021
Biostatistics Center, Kurume University, Fukuoka, Japan.
Background: Plaque psoriasis significantly affects patients' health-related quality of life. To aid treatment decisions, not only objective assessment by physicians but also subjective assessment by patients is important.
Objective: To assess the significance of Dermatology Life Quality Index (DLQI) evaluation at the time of biologics introduction in clinical practice in Japanese patients with plaque psoriasis.
JAMA Dermatol
October 2019
Janssen Pharmaceutical K.K., Tokyo, Japan.
Importance: Palmoplantar pustulosis (PPP) causes erythematous, scaly plaques with recurrent sterile pustules refractory to treatment and with few randomized clinical trials conducted. Evidence points to involvement of interleukin 23 in the pathogenesis of PPP.
Objective: To determine the efficacy and safety of guselkumab, an anti-IL-23 monoclonal antibody, in Japanese patients with PPP.